Detalles de la búsqueda
1.
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Eur Respir J;
61(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37230499
2.
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model.
Br J Clin Pharmacol;
88(7): 3500-3505, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043423
3.
Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
J Pediatr;
204: 225-233.e8, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30314658
4.
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.
Br J Clin Pharmacol;
83(8): 1773-1781, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28230269
5.
Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases.
Ther Drug Monit;
39(4): 308-315, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28230618
6.
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases.
Ther Drug Monit;
39(4): 339-343, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28486309
7.
Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling.
Ther Drug Monit;
39(4): 322-326, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28703717
8.
Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publications.
Br J Clin Pharmacol;
87(3): 1594-1595, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269471
9.
Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials.
Basic Res Cardiol;
110(2): 11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25653117
10.
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations.
Therapie;
69(4): 355-66, 2014.
Artículo
en Inglés, Francés
| MEDLINE | ID: mdl-25099666
11.
Rationale and design of the French cohort of acute myocarditis diagnosed by cardiac magnetic resonance imaging (MyocarditIRM).
Arch Cardiovasc Dis;
2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797639
12.
Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan.
Br J Clin Pharmacol;
84(5): 1072-1074, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29512176
13.
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.
BMC Med Res Methodol;
13: 107, 2013 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24229055
14.
Blood pressure management and long-term outcomes in kidney transplantation: a holistic view over a 35-year period.
J Nephrol;
36(7): 1931-1943, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548826
15.
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
PLoS Med;
9(4): e1001204, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22509138
16.
Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study.
Nephrol Dial Transplant;
27(7): 2886-91, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22344775
17.
False positive results in preclinical research.
Therapie;
72(4): 411-413, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27567552
18.
Farnesoid X receptor targeting for hepatitis C: study protocol for a proof-of-concept trial.
Therapie;
67(5): 423-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23241251
19.
The IDEAL study : towards personalized drug treatment of hypertension.
Therapie;
67(3): 195-204, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22874485
20.
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.
Clin Pharmacokinet;
61(1): 143-154, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351609